Abstract
Potential markers and the mechanism of the spontaneous transformation of multipotent stromal cells (MSC) with perivascular immunophenotype have been determined. A transcriptome comparative study was performed involving six paired specimens of normal and spontaneously transformed MSC with perivascular immunophenotype, obtained in the first passages following the isolation of adipose tissue of six healthy donors. According to the results obtained using the microarray Illumina HT-12 v4 with the Significance Analysis of Microarrays software, differentially expressed transcripts were revealed and a statistical analysis using Gene Ontology and Molecular Signatures Databases was conducted. The association of the spontaneous transformation of isolated MSC with perivascular immunophenotype with previously identified oncogenic cell transformation pathways (E2F, ATR/ATM, RAS, and RHOA) is suggested and further aims for more detailed study are set. Potential transformation markers, including largely unknown genes and those previously not associated with cancer genes (HSPB6, PLAC9, FEZ1, DTWD1, APH1A, and ATP5L), are described.
Similar content being viewed by others
References
Wirths, S., Malenke, E., Kluba, T., et al., Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas, Stem Cells Transl. Med., 2013, vol. 2, no. 1, pp. 53–60.
Rodriguez, R., Rubio, R., and Menendez, P., Modeling sarcomagenesis using multipotent mesenchymal stem cells, Cell Res., 2012, vol. 22, no. 1, pp. 62–77.
Klopp, A.H., Gupta, A., Spaeth, E., et al., Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?, Stem Cells, 2011, vol. 29, no. 1, pp. 11–19.
Lazennec, G. and Jorgensen, C., Concise review: adult multipotent stromal cells and cancer: risk or benefit?, Stem Cells, 2008, vol. 26, no. 6, pp. 1387–1394.
Omelchenko, D.O., Rzhaninova, A.A., Fedyunina, I.A., et al., Analysis of chromosome set and aberrations in spontaneously immortalized multipotent mesenchymal stromal cells from different human tissues, Med. Genet., 2012, vol. 11, no. 11, pp. 32–36.
Rzhaninova, A.A., Kulikov, A.V., Spirova, I.A., et al., Preparation and characterization of culture of CD146+ cells from human adipose tissue, Kletochnye Tekhnol. Biol. Med., 2010, no. 1, pp. 3–9.
Du, P., Kibbe, W.A., and Lin, S.M., Lumi: a pipeline for processing illumina microarray, Bioinformatics, 2008, vol. 24, no. 13, pp. 1547–1548.
McClintick, J.N. and Edenberg, H.J., Effects of filtering by present call on analysis of microarray experiments, BMC Bioinform., 2006, vol. 7, no. 1, pp. 49–64.
Miller, J.A., Cai, C., Langfelder, P., et al., Strategies for aggregating gene expression data: the collapseRows R function, BMC Bioinform., 2011, vol. 12, no. 1, pp. 322–334.
Eden, E., Navon, R., Steinfeld, I., et al., GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists, BMC Bioinform., 2009, vol. 10, no. 1, pp. 48–54.
Subramanian, A., Tamayo, P., Mootha, V.K., et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 2005, vol. 102, no. 43, pp. 15545–15550.
Smith, J., Tho, L.M., Xu, N., and Gillespie, D.A., The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer, Adv. Cancer Res., 2010, vol. 108, pp. 73–112.
Chang, S., Chromosome ends teach unexpected lessons on DNA damage signaling, EMBO J., 2012, vol. 31, no. 16, pp. 3380–3381.
Müller, H. and Helin, K., The E2F transcription factors: key regulators of cell proliferation, Biochim. Biophys. Acta, 2000, vol. 1470, no. 1, pp. 1–12.
van Vlerken, L.E., Kiefer, C.M., Morehouse, C., et al., EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter, Stem Cells Transl. Med., 2013, vol. 2, no. 1, pp. 43–52.
Fridman, A.L. and Tainsky, M.A., Critical pathways in cellular senescence and immortalization revealed by gene expression profiling, Oncogene, 2008, vol. 27, no. 46, pp. 5975–5987.
Huang, G., Eisenberg, R., Yan, M., et al., 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer, Cancer Res., 2008, vol. 68, no. 13, pp. 5040–5048.
Berenjeno, I.M., Núñz, F., and Bustelo, X.R., Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases, Oncogene, 2007, vol. 26, no. 29, pp. 4295–4305.
Lindvall, C., Hou, M., Komurasaki, T., et al., Molecular characterization of human telomerase reverse trans- criptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene, Cancer Res., 2003, vol. 63, no. 8, pp. 1743–1747.
Chiaradonna, F., Sacco, E., Manzoni, R., et al., Ras-dependent carbon metabolism and transformation in mouse fibroblasts, Oncogene, 2006, vol. 25, no. 39, pp. 5391–5404.
Ishida, S., Huang, E., Zuzan, H., et al., Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis, Mol. Cell Biol., 2001, vol. 21, no. 14, pp. 4684–4699.
Oxford, G., Smith, S.C., Hampton, G., and Theodorescu, D., Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector, Oncogene, 2007, vol. 26, no. 50, pp. 7143–7152.
Lee, J.H., Horak, C.E., Khanna, C., et al., Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility, Cancer Res., 2008, vol. 68, no. 3, pp. 639–644.
Lasham, A., Print, C.G., Woolley, A.G., et al., YB-1: oncoprotein, prognostic marker and therapeutic target?, Biochem. J., 2013, vol. 449, no. 1, pp. 11–23.
Thollet, A., Vendrell, J.A., Payen, L., et al., ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells, Mol. Cancer, 2010, vol. 9, no. 1, pp. 291–307.
Vendrell, J.A., Thollet, A., Nguyen, N.T., et al., ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion, Cancer Res., 2012, vol. 72, no. 14, pp. 3593–3606.
Zeller, K.I., Jegga, A.G., Aronow, B.J., et al., An integrated database of genes responsive to the Myc onco- genic transcription factor: identification of direct genomic targets, Genome Biol., 2003, vol. 4, no. 10, pp. 1–10.
Kaur, M. and Cole, M.D., MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase, Cancer Res., 2013, vol. 73, no. 2, pp. 695–705.
Okuyama, H., Endo, H., Akashika, T., et al., Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose, Cancer Res., 2010, vol. 70, no. 24, pp. 10213–10223.
Ferreira, B.I., Alonso, J., Carrillo, J., et al., Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing’s sarcoma, Oncogene, 2008, vol. 27, no. 14, pp. 2084–2090.
Nielsen, T.O., West, R.B., Linn, S.C., et al., Molecular characterization of soft tissue tumors: a gene expression study, Lancet, 2002, vol. 359, no. 9314, pp. 1301–1307.
Anastassiou, D., Rumjantseva, V., Cheng, W., et al., Human cancer cells express slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo, BMC Cancer, 2011, vol. 11, no. 1, pp. 529–537.
Riggi, N., Suvá, M.L., Suvá, D., et al., EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells, Cancer Res., 2008, vol. 68, no. 7, pp. 2176–2185.
Ren, Y.X., Finckenstein, F.G., Abdueva, D.A., et al., Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations, Cancer Res., 2008, vol. 68, no. 16, pp. 6587–6597.
Novikova, N.I., Rzhaninova, A.A., Skobtsova, L.A., et al., Study of biological safety of cell cultures of mesenchymal stromal cells in immunodeficient mouse lines Nu/Nu B/C, Toksikol. Vestn., 2011, no. 2, pp. 13–19.
Xia, J., Wang, F., Wang, L., and Fan, Q., Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway, Tumour Biol., 2013, vol. 34, no. 1, pp. 317–328.
Wang, N., Eckert, K.A., Zomorrodi, A.R., et al., Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways, PLoS One, 2012, vol. 7, no. 6, p. e39446.
Wang, X., Zhao, T., Huang, W., et al., Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors, Stem Cells, 2009, vol. 27, no. 12, pp. 3021–3031.
Ke, L., Meijering, R.A., Hoogstra-Berends, F., et al., HSPB1, HSPB6, HSPB7 and HSPB8 protect against Rhoa GTPase-induced remodeling in tachypaced atrial myocytes, PLoS One, 2011, vol. 6, no. 6, p. e20395.
Grotsky, D.A., Gonzalez-Suarez, I., Novell, A., et al., BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells, J. Cell Biol., 2013, vol. 200, no. 2, pp. 187–202.
Ocaña, O.H., Córcoles, R., Fabra, A., et al., Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1, Cancer Cell, 2012, vol. 22, no. 6, pp. 709–724.
Hirohata, S., Wang, L.W., Miyagi, M., et al., Punctin, a novel ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix, J. Biol. Chem., 2002, vol. 277, no. 14, pp. 12182–12189.
Du, J., Takeuchi, H., Leonhard-Melief, C., et al., O-Fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation, Dev. Biol., 2010, vol. 346, no. 1, pp. 25–38.
Humtsoe, J.O., Liu, M., Malik, A.B., and Wary, K.K., Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures, Mol. Cell Biol., 2010, vol. 30, no. 7, pp. 1593–1606.
Matsumine, A., Shintani, K., Kusuzaki, K., et al., Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors, J. Surg. Oncol., 2007, vol. 96, no. 5, pp. 411–418.
Goldoni, S. and Iozzo, R.V., Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs, Int. J. Cancer, 2008, vol. 123, no. 11, pp. 2473–2479.
Pardali, E., van der Schaft, D.W., Wiercinska, E., et al., Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma, Oncogene, 2011, vol. 30, no. 3, pp. 334–345.
Majid, S.M., Liss, A.S., You, M., and Bose, H.R., The suppression of SH3BGRL is important for v-Rel-mediated transformation, Oncogene, 2006, vol. 25, no. 5, pp. 756–768.
Orso, F., Penna, E., Cimino, D., et al., AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs, FASEB J., 2008, vol. 22, no. 8, pp. 2702–2714.
Skubitz, K.M., Pambuccian, S., Manivel, J.C., and Skubitz, A.P., Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors, J. Transl. Med., 2008, vol. 6, no. 1, pp. 23–35.
Santo, E.E., Ebus, M.E., Koster, J., et al., Oncogenic activation of FOXR1 by 11q23 intrachromosomal dele-tion-fusions in neuroblastoma, Oncogene, 2012, vol. 31, no. 12, pp. 1571–1581.
Leandro-García, L.J., Leskelä, S., Landa, I., et al., Tumoral and tissue-specific expression of the major human beta-tubulin isotypes, Cytoskeleton (Hoboken), 2010, vol. 67, no. 4, pp. 214–223.
Hirst, M., Haliday, E., Nakamura, J., and Lou, L., Human GMP synthetase: protein purification, cloning, and functional expression of cDNA, J. Biol. Chem., 1994, vol. 269, no. 38, pp. 23830–23837.
Carnero, A., Blanco-Aparicio, C., Renner, O., et al., The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications, Curr. Cancer Drug Targets, 2008, vol. 8, no. 3, pp. 187–198.
Tiganis, T., Bennett, A.M., Ravichandran, K.S., and Tonks, N.K., Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase, Mol. Cell Biol., 1998, vol. 18, no. 3, pp. 1622–1634.
Omerovic, J., Clague, M.J., and Prior, I.A., Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells, Biochem. J., 2010, vol. 426, no. 1, pp. 65–72.
Wang, Y.L., Wang, Y., Tong, L., and Wei, Q., Overexpression of calcineurin B subunit (CnB) enhances the oncogenic potential of HEK293 cells, Cancer Sci., 2008, vol. 99, no. 6, pp. 1100–1108.
Kasper, G., Vogel, A., Klaman, I., et al., The human LAPTM4b transcript is upregulated in various types of solid tumors and seems to play a dual functional role during tumor progression, Cancer Lett., 2005, vol. 224, no. 1, pp. 93–103.
Dubash, A.D., Guilluy, C., Srougi, M.C., et al., The small GTPase RhoA localizes to the nucleus and is activated by Net1 and DNA damage signals, PLoS One, 2011, vol. 6, no. 2, p. e17380.
Bennett, G., Sadlier, D., Doran, P.P., et al., A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer, BMC Cancer, 2011, vol. 11, pp. 50–60.
Chen, L., Li, X.Y., Wang, Y., et al., [Expression and significance of NET-1 protein in hepatocellular carcinoma], Zhonghua Zhong Liu Za Zhi, 2007, vol. 29, no. 12, pp. 917–921.
Qin, H., Carr, H.S., Wu, X., et al., Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1, J. Biol. Chem., 2005, vol. 280, no. 9, pp. 7603–7613.
Lee, M.H. and Surh, Y.J., eEF1A2 as a putative oncogene, Ann. N.Y. Acad. Sci., 2009, vol. 1171, pp. 87–93.
Amiri, A., Noei, F., Jeganathan, S., et al., eEF1A2 activates Akt and stimulates Akt-dependent actin remodel- ing, invasion and migration, Oncogene, 2007, vol. 26, no. 21, pp. 3027–3040.
Sun, Y., Wong, N., Guan, Y., et al., The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas, Int. J. Cancer, 2008, vol. 123, no. 8, pp. 1761–1769.
Citi, S., Paschoud, S., Pulimeno, P., et al., The tight junction protein cingulin regulates gene expression and RhoA signaling, Ann. N.Y. Acad. Sci., 2009, vol. 1165, pp. 88–98.
Papageorgis, P., Lambert, A.W., Ozturk, S., et al., Smad signaling is required to maintain epigenetic silencing during breast cancer progression, Cancer Res., 2010, vol. 70, no. 3, pp. 968–978.
McDowell, C.L., Bryan Sutton, R., and Obermann, W.M., Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue, Int. J. Biol. Macromol., 2009, vol. 45, no. 3, pp. 310–314.
Gronthos, S., McCarty, R., Mrozik, K., et al., Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues, Stem Cells Dev., 2009, vol. 18, no. 9, pp. 1253–1262.
Pirone, D.M., Fukuhara, S., Gutkind, J.S., and Burbelo, P.D., SPECs, small binding proteins for Cdc42, J. Biol. Chem., 2000, vol. 275, no. 30, pp. 22650–22656.
Gotoda, T., Matsumura, Y., Kondo, H., et al., Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma, Gut, 2000, vol. 46, no. 1, pp. 14–19.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.O. Omelchenko, A.A. Rzhaninova, D.V. Goldshtein, 2014, published in Genetika, 2014, Vol. 50, No. 1, pp. 106–115.
Rights and permissions
About this article
Cite this article
Omelchenko, D.O., Rzhaninova, A.A. & Goldshtein, D.V. Comparative transcriptome pairwise analysis of spontaneously transformed multipotent stromal cells from human adipose tissue. Russ J Genet 50, 96–104 (2014). https://doi.org/10.1134/S1022795414010098
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795414010098